Related Experiment Videos

Immune-mediated cholangitis: is it always nivolumab's fault?

Francesco Gelsomino¹, Giovanni Vitale², Andrea Ardizzoni²

¹Medical Oncology Unit, Policlinico S. Orsola-Malpighi, University of Bologna, Via Albertoni 15, 40138, Bologna, Italy. francesco_gelsomino@aosp.bo.it.

Cancer Immunology, Immunotherapy : CII

|April 7, 2018

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Prognostic value of different metabolic response criteria in patients with advanced melanoma treated with immunotherapy: a comparative analysis of PECRIT, PERCIMT, and EORTC criteria.

European journal of nuclear medicine and molecular imaging·2026

Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Differential Virulence of Vaginal Candida albicans Isolates Correlates with Host Inflammatory Responses in VVC/RVVC.

Journal of fungi (Basel, Switzerland)·2026

Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Case Report: The "atoll sign": a case series on an unusual radiological pattern of immune-mediated pneumonitis.

Frontiers in immunology·2026

Cancer of unknown primary genomic profiling from cell-free DNA provides insights into CUP biology and vulnerabilities.

Frontiers in medicine·2026

See all related articles